Chad N. White - 03 Oct 2022 Form 3 Insider Report for Sonoma Pharmaceuticals, Inc. (SNOA)

Role
Interim CFO
Signature
/s/ Chad N. White
Issuer symbol
SNOA
Transactions as of
03 Oct 2022
Net transactions value
$0
Form type
3
Filing time
12 Oct 2022, 17:03:40 UTC
Next filing
30 Dec 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding SNOA Stock Option (right to buy) 03 Oct 2022 Common Stock 5,000 $2.21 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Issuer granted the options as an initial grant upon Mr. White's appointment as interim Chief Financial Officer of the Issuer. The options vest in three equal tranches annually on the grant date anniversary, beginning on October 3, 2023 and becoming fully vested on October 3, 2025, or upon change of control of the Issuer.